The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”) today announced that Company’s Prospectus was approved by Polish Financial Supervision Authority. The Prospectus was prepared for the purpose of conducting the public offering of up to 3,200,000 of new shares of the Company’s common stock and introduction and admission of up to 25,200,000 shares of the Issuer’s common stock to a regulated market of the Warsaw Stock Exchange. The Offering Agent is Vestor Dom Maklerski S.A. The Prospectus will be published on the Company’s website (www.medicalmilestone.com).
Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”.
Osoby reprezentujące spółkę:
Joseph D'Agostino - CFO